Personalized Medicine through Genomic Analysis and Molecular Diagnostics

Monday, October 6, 2008 
at 
The Princeton Club of New York
located at
15 West 43rd Street (b/w Fifth and Sixth Avenues)
New York, New York, U.S.A. 10036

Overview:

The TriMark Molecular Diagnostics 2008 Conference has been organized to provide a critical examination of the molecular diagnostics industry, as well as insight from key industry leaders concerning cutting edge molecular diagnostics technology, structuring mutually beneficial deals and the molecular diagnostics industry’s impact on the field of in vitro diagnostics. This conference will also provide an integral forum for leaders in molecular diagnostics, in vitro diagnostics and laboratories to share ideas, network with other delegates and advance understanding of the potential of new molecular diagnostics technologies. 

Who Should Attend:

• Molecular diagnostics companies.
• In vitro diagnostic companies.
• Biotechnology companies.
• Medical device manufacturers.

Leaders from the Following Areas Will Greatly Benefit from Attending:

• Laboratory leaders.
• Hospital CFOs and CSOs.
• Molecular diagnostics and in vitro diagnostic companies.
• Business development.
• Strategic planning and development.
• Technology development.
• Marketing.
• Research and development.

Key Themes:

• A critical examination of key emerging technologies applicability to molecular diagnostics.
• Formation of successful alliances.
• Partnering of emerging technologies with molecular diagnostics.
• Transitioning from laboratory in vitro diagnostics to molecular diagnostics.
• The emerging role of molecular diagnostic tests in personalized medicine.
• The intersection of pharmacogenomics and molecular diagnostics with personalized medicine.

Questions Answered in the TriMark Conference:

• What will the molecular diagnostics market be worth by the end of the decade?
• Which market key segments will drive molecular diagnostics market growth?
• Which new technologies will reach the molecular diagnostics market in the next 2-3 years?
• How is technology innovation impacting the dynamics and ownership of the molecular diagnostics industry?
• How can clinical labs bring in new molecular diagnostic tests?
• What are the key challenges in gaining acceptance of new technologies by users, payers and regulators?
• How is technology innovation facilitating the transition of molecular diagnostics testing into standard healthcare practice?

Top Five Reasons To Attend the TriMark Conference:

• Discover the molecular diagnostics sectors with the greatest prospective growth, ensuring you can successfully align your future strategies with predicted success.
• Evaluate the competitive dynamics of the molecular diagnostics market and understand the changing relationship between IVD companies and the molecular diagnostics testing sector.
• Identify the key players in the molecular diagnostics market, recognize lucrative partnering opportunities and benchmark your strategies against the leading players.
• Assess opportunities and challenges faced by diagnostic companies in gaining acceptance of innovative technologies by payers, regulators and users.
• Understand the factors driving growth of the molecular diagnostics market.

Registration Fees for the Conference:

• Early-Bird Registration Fee is $795 until August 31, 2008. 
• Standard Registration Fee is $995 on and after September 1, 2008. 
• At-the-Door Fee (on October 6, 2008; subject to seating availability) is $1200. 

Schedule:

• Registration at 8:00 am
• Seated lunch at 12:00 pm
• Cocktails/networking at 5:00 pm. 

(Note: The Princeton Club has a business attire dress code.)

How to Register for the Conference:

Online:

Buy Tickets Here

Email: